Baxter expects 2026 total sales growth to be flat to 1% on a reported basis, with organic sales growth approximately flat. The company projects an adjusted EPS of $1.85 to $2.05 per diluted share for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results